Cardiovascular diseases: Thromboembolic disease Circulatory System Thromboembolic disease
Conditions
Interventions
A randomised, open clinical trial in a single centre of four investigational protocols: patients are randomised into one of the protocols.
1. V/Q scan +/- lower limb doppler ultrasound +/- clinical as
Sponsors
Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients suspected of acute pulmonary embolus normally investigated with ventilation-perfusion (V/Q) radionucleide scanning. 18 years or greater. Giving informed consent.
Exclusion criteria
Exclusion criteria: Unable to give informed consent. Pregnant. Contraindication to any one of the above protocols.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Follow-up will monitor: Days in hospital. Other investigations. Treatment costs. Recurrent thrombo-embolic disease in three months following investigation. Readmission and subsequent costs. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration. | — |
Countries
United Kingdom
Outcome results
None listed